Recently the M 17S 1 gene, encoding an epidermal antigen thought to play a role in cell adhesion, was mapped to chromosome b ands 17q 11 -q 12, placing it in the vicinity of the gene for the genetic disorder neurofibromatosis I (NF 1). The pleomorphic cutaneous lesions of NF 1 and the precedent for other genes being embedded within the NF1 gene prompted us to investigate whether the M17S1 gene mapped near, or within, the NF1 gene. Genetic linkage analyses revealed that M17S1 was tightly linked to NF1 and mapped within the interval bounded by D 17S58 and D 17S54. Physical mapping of an M17S1 cDNA on somatic cell hybrids, yeast artificial chromosomes, and an NF1 patient with a deletion involving an entire NF 1 allele demonstrated that M17S1 is located at least 180 kb centromeric to the NF 1 gene. The distance between the genes suggests that M17S1 is unlikely to contribute to the NF1 phenotype since a gross chromosomal rearrangement would be required to disrupt expression of both genes.
INTRODUCTION
The epidermis is composed of keratinocytes that are continually differentiating and being pushed upward from the mitotic basal layer at the dermal-epidermal junction to the outer surface of the skin. The identification and study of differentiation-specific gene products has been a valuable strategy for investigating the structure, composition, and function of normal skin and the pathobiology of skin disorders (Fuchs, 1990; Fine et al., 1991) . Several years ago, a 35-kDa human epidermal protein was identified by the murine monoclonal antibody ECS-1 isolated from a mouse injected with cultured human foreskin keratinocytes (Negi et al., 1986) . The ECS-1 antibody induced a complement-enhanced epidermal cell detachment activity suggesting that the 35-kDa protein may play a role in cell adhesion (Negi et al., 1986) . The cDNA encoding the 35-kDa protein, named ESA for epidermal surface antigen, was recently cloned, and the DNA sequence predicted a peptide of 290 amino acids in length. The cloning, sequence, and tissue-specific expression of ESA will be reported elsewhere (W. Schroeder, unpublished data) .
The ESA gene, designated M17S1, was mapped by in situ hybridization to human chromosome bands 17qll-q12 (Schroeder et al., 1991) . We found it intriguing that M17S1 was located in the vicinity of the gene for neurofibromatosis 1, a disorder with multiple skin manifestations, located at 17q11.2 (Schmidt et al., 1987; Ledbetter et al., 1989) . Neurofibromatosis 1 (NF1) is a common autosomal dominant genetic disorder affecting 1 of 3000 individuals (Crowe et al., 1956) . The skin manifestations include cutaneous and subcutaneous neurofibromas, caf6-au-lait spots (hyperpigmented skin patches), and freckling in the armpit and groin. Neurofibromas can also be of the plexiform type, affecting a bundle(s) of nerves; hyperpigmentation and hypertrichosis (excessive hair) of the skin overlying the tumor are common. In addition to the skin manifestations, Lisch nodules of the iris, optic glioma, and certain bony abnormalities are diagnostic features of NF1. Affected individuals commonly have associated findings such as macrocephaly, scoliosis, learning disabilities, and increased risk of malignancy. Reviews of the clinical presentation of NF1 have been published (Riccardi, 1992; Stumpf et al., 1988; Rubenstein and Korf, 1990; Huson et al., 1989) .
The NF1 gene is large and structurally complex. The gene, estimated at 300 kb in length, produces a transcript of approximately 13 kb, and a predicted protein, designated neurofibromin, of 2818 amino acids Marchuk et al., 1991) . During the search for the NF1 transcript, three small genes that mapped within a single large intron of the NF1 gene were identified, transcribed from the alternate strand (Cawthon et al., 1990a,b; O'Connell et al., 1990; Viskochil et al., 1991) . Two of the embedded genes, EVI2A and EVI2B, are the h u m a n h o m o l o g s o f m u r i n e s e q u e n c e s w h e r e r e t r o v i r a l i n t e g r a t i o n r e s u l t s in m u r i n e m y e l o i d t u m o r e x p r e s s i o n ( B u c h b e r g et al ., 1990) . T h e t h i r d gene, o l i g o d e n d r oc y t e -m y e l i n g l y c o p r o t e i n ( O M G P ) , is a c o m p o n e n t of u n k n o w n f u n c t i o n o f c e n t r a l n e r v o u s s y s t e m m y e l i n ( M i k o l a n d S t e f a n s s o n , 1988).
T h e m o l e c u l a r b a s e s for t h e i n t e r -a n d i n t r a f a m i l i a l v a r i a b l e e x p r e s s i v i t y t h a t is a h a l l m a r k of t h e N F 1 diso r d e r h a v e y e t to be identified. A role of N F 1 locus h e te r o g e n e i t y as a m a j o r c o n t r i b u t o r y f a c t o r to i n t e r f a m i l i a l v a r i a b i l i t y a p p e a r s u n l i k e l y . G e n e t i c l i n k a g e s t u d i e s b y a n i n t e r n a t i o n a l c o n s o r t i u m i n v o l v i n g 142 m u l t i g e n e r at i o n a l N F 1 f a m i l i e s s u p p o r t t h e h y p o t h e s i s of a single , 1992) . T h i s is a n i m p o r t a n t o b s e r v at i o n since a p p r o x i m a t e l y 50% of cases are due to a p p a re n t n e w m u t a t i o n in t h e N F 1 gene (Crowe et al., 1956; R i , 1991) . I t r e m a i n s to be d e t e r m i n e d w h e t h e r a n y genes e m b e d d e d in, or a d j a c e n t to, t h e N F 1 gene c o n t r i b u t e to t h e v a r i a b l e p h e n o t y p e . T h e s k i n m a n i f e s t a t i o n s a n d v a r i a b l e e x p r e s s i v i t y of t h e N F 1 d i s o r d e r a n d t h e p r e c e d e n t for o t h e r genes m a p p i n g w i t h i n t h e N F 1 gene p r o m p t e d us to d e t e r m i n e w h e t h e r t h e M 1 7 S 1 gene m a p p e d n e a r , or w i t h i n , t h e N F 1 gene.
c c a r d i , 1992). I t h a s b e e n p r o p o s e d t h a t m u t a t i o n s d i s r u p t i n g a

MATERIALS AND METHODS
Families and DNA markers. Previously, we constructed a genetic map of eight loci in the pericentromeric region of chromosome 17 using data collected on 50 NF1 families . The markers, with locus designations in parentheses, included p17H8 (D17Z1), A10-41 (D17S71), pEW301 (D17S58), pEW206 (D17S57), pEW207 (D17S73), pEW203 (D17S54), L581 (D17S37), and L946 (D17S36). For the current study, we chose 18 families with individuals previously determined to have a recombination event in the chromosome 17 pericentromeric region ; these families were BAY& BAY13, BAY14, BAY17, BAY21, BAY25, BAY28, BAY31, BAY34, BAY35, BAY40, BAY45, BAY58, BAY77, BAY78, UMI4, UMI5, and UMI16. Family prefixes, designating the institution where the families were ascertained, are as established previously by the NF1 international genetic linkage consortium Goldgar et al., 1989) . Accordingly, NF1 patients/families ascertained at the University of Washington are designated with the UWA prefix. In this study, these 18 families were typed with seven additional probe/enzyme systems (locus designations in parentheses) including pESA2-PstI (M17S1; W. Schroeder, unpublished data), pVAW21OM2-MspI (D17Sl15), pVAW212-PstI (D17Sl17), p~8-2- MspI (CRYB1; fl-crystallin gene), pVAW215R3-TaqI (D17S120) (Fain et al., 1989) , pHHH202-RsaI (D17S33; White et al., 1987), and pTH17.19-BglII (D17S82; O'Connell et al., 1989) . pESA2 is a 2.0-kb partial cDNA of M17S1. Two NF1 cDNAs were used in the YAC studies; GE2 is a partial cDNA from the 5' end, and P5 is a partial cDNA from the 3' end of the gene Marchuk et al., 1991) .
Somatic cell hybrids, cell lines, and YACs. DCR-1 and NF13 are human-mouse somatic cell hybrids carrying human derivative chromosomes from two unrelated NF1 patients with translocation breakpoints within the NF1 gene. DCR-1 has a derivative chromosome 1 (lqter-p34.3: : 17ql 1-qter; Schmidt et al., 1987; Menon et al., 1989) and NF13 a derivative chromosome 22 (22pter-22qll.2::17qll.2-17qter; Ledbetter et al., 1989) . The NF13 breakpoint maps approximately 60 kb q-distal to the DCR-1 breakpoint . The SP3-10 hybrid contains a human derivative chromosome 15 (15pter-q22:: 17qll-17qter; Sheer et al., 1983 Sheer et al., , 1985 . MH22.6 carries an intact chromosome 17 as its only human genomic component (van Tuinen et al., 1987) . The LMTk-mouse cell line was the fusionrecipient for construction of DCR-1, NF13, and MH22.6 (van Tuinen et al., 1987) . Cell lines were obtained from the American Type Culture Collection (Rockville, MD). UWA106-3 is an immortalized lymphoblastoid cell line from an NF1 patient with an extensive deletion encompassing the entire NF1 paternal allele and four flanking loci including D17S120, D17Sl15, D17S57, and D17S73 (Kayes et al., 1992) . The three overlapping yeast artificial chromosome (YAC) clones A43A9, D8F4, and A113D7 form a contig that spans the NF1 gene (Marchuk et al., 1992) . DNA from non-YAC-bearing yeast was a gift of Lee Hartwell.
DNA hybridization. Genomic DNA was purified from peripheral blood, immortalized lymphoblastoid cell lines, somatic ceil hybrids Note. Pairwise lod scores calculated at 0 m = Of; 2, maximum lod score, 0, recombination fraction at £. (Bell et al., 1981) , or YAC-containing yeast (Sherman et al., 1986) . Five micrograms of human genomic DNA or 13 #g of DNA from hybrid cell lines was digested with restriction enzymes (5 U/#g; Boehringer-Mannheim, Indianapolis) according to the manufacturer's directions, with the exception of TaqI and MspI, which were digested at 67°C and room temperature, respectively, to minimize partial digestion products . The extent of the digestion was assessed in a second parallel test reaction (Schumm et al., 1988) : a volume (6 #1) of the original digestion reaction, containing 1 #g of human DNA, was added to 1 #g X DNA. Complete digestion was assumed if the X DNA digest appeared complete upon ethidium bromide staining after agarose gel electrophoresis of the test reactions. Any original DNA-digested samples that were judged as incomplete were redigested with 2-5 U/#g DNA for 8-12 h. Digested samples were electrophoresed through 0.8% agarose at 1.7 V/cm for 24-30 h. Gels were denatured 30 min in 0.5 M NaOH and 1.5 M NaC1 and transferred overnight by capillary action to Zetabind membrane (AMF Cuno, Meriden, CT). For detection of restriction fragment length polymorphisms (RFLPs), cloned human DNA inserts were labeled in situ with their vector sequences by primer extension (Feinberg and Vogelstein, 1983) . For hybridization to membranes with NF1-YAC DNAs, which carry plasmid sequences homologous to many of the probes, the human DNA insert was isolated from the probe vector by restriction enzyme digestion, electrophoresis, and recovery on NA45 DEAE membrane (Schleicher and Schuell, Keene, NH) before labeling. Hybridization was as previously described . The copy number of the M17S1 gone in deletion patient UWA106-3 was assayed by densitometry. A Southern blot membrane with DNA from UWA106-3 and unrelated, non-NF individuals was sequentially hybridized to M17S1 and L946. L946 was chosen to control for variation in DNA concentration among the sample lanes because it lies outside the deleted region of UWA106-3 (Kayes et al., 1992) and hybridizes to fragments of similar size as M17S1. The resulting autoradiograms were scanned with a Hoefer GS300 densitometer and Macintosh II computer. The density ratio of the 3.1-kb invariant band revealed by M17S1 (Fig. 3B) to the density of the 2.4-kb invariant band revealed by L946 (Fig. 3C) Linkage analysis. Two-point and multipoint linkage analyses were performed with the program CRI-MAP Version 2.4 (P. Green, unpublished data; Barker etal., 1987; Donis-Keller et al., 1987) . The ALL option of the program was used to calculate the likelihood that the M17S1 locus mapped in any one marker interval on a map of 15 pericentromeric loci. The unique order of loci shown in Fig. 2 is based on genetic and physical data Fain et al., 1989; Fountain etal., 1989) ; there are two ambiguities in locus order as summarized in Fig . 
Genetic Mapping of the M17S1 Gene
The segregation of alleles for the PstI R F L P of M17S1 and RFLPs for 6 other loci described under Materials and Methods were determined in the 18 NFl-affected families. Pairwise lod scores between M17S1 and 5 of these loci, plus 8 loci from our previous studies and the NF1 phenotype , are given in Table 1 , in order of decreasing lod score. The pairwise lod scores, calculated under the hypothesis of equal recombination frequency in males and females, show that the M17S1 and NF1 genes are tightly linked giving a maximum lod score of 6.62 at a 0 of 0.00. Lod scores exceeding 3.0, significant evidence in favor of linkage, were also obtained for D17S57, D17S73, and D17S54 (Table 1) . No recombination events were detected between M17S1 and either D17S57 or D17S73 (Table 1) . Pairwise lod scores between M17S1 and 10 other loci were positive but not statistically significant (Table 1) . Two-point lod scores for M17S1 and D17S82 are not shown since no meioses were jointly informative at both loci. Significant evidence in favor of excluding tight linkage between the most q-distal locus, D17S36, and M17S1 was obtained (Table 1) . A lod score of -2.0 at 0 = 0.009 excludes M17S1 from a location within approximately 1% recombination either side of the D17S36 locus.
A B 1 2 3 4 1 2 3 4 plays the maximum likelihood phase choice for ordered loci on the two chromosomes of each offspring, was used to detect loci involved in recombination events. Data for all loci involved in recombination events were checked for accuracy; all families have been screened for possible nonpaternities .
RESULTS
RFLP Revealed by M17S1
To facilitate genetic mapping, we screened DNA from five unrelated individuals digested with 11 different restriction enzymes for an R F L P revealed by the M17S1 gene. DNA fragments of variant length were observed in the PstI-digested samples; no fragment size variations were observed in digests involving BamHI, BglII, EcoRI, HindIII, HinfI, HpaII, MspI, PvuII, TaqI, or Goldgar et al., 1989; Fain et al., 1989; O'Connell et al., 1989) . Diagram is not drawn to scale; refer to Fig. 2 for genetic distances. Two ambiguities in locus order are indicated above the map; the order of D17S120 and D17Sl17 may be reversed and the position of D17Sl15 with respect to D17S57 and D17S73 is not known. Below the map, subchromosomal fragments present in the hybrid cell lines and the deletion patient UWA106-3 are indicated. The expanded region is a physical map of the NF1 gene, drawn to scale, showing the endpoints of chromosome 17 segments carried by the translocation hybrids DCR-1 and NF13 and the NF1-YACs. YAC D8F4 is chimeric; the wavy line represents human DNA from an unknown locus (Marchuk et al., 1992) . The approximate positions of the NF1 cDNAs GE2 and P5 are indicated. +, Hybridization to M17S1 on Southern blot analysis; -, no significant hybridization to M17S1.
Multipoint genetic linkage analyses were performed to map the M17S1 gene relative to NF1 and other loci in the 17q proximal region. Figure 2 summarizes the relative probability that M17S1 maps to any one of 10 interlocus intervals. Significant evidence in favor of excluding placement (relative odds >1:100) of M17S1 outside of the interval bounded by D17S58 and D17S54 was obtained (Fig. 2) .
Physical Mapping of the M17S1 Gene
Somatic cell hybrids carrying subchromosomal regions of human chromosome 17 were used to refine the location of the M17S1 gene. The locations of the breakpoint(s) carried by each hybrid are diagramed in Fig. 5 . All hybrid cell lines display fragments that comigrate with murine-specific fragments in the LMTk-murine cell line (Fig. 3A, lane 2) . MH22.6, a human chromosome 17 hybrid (lane 1), displays the expected human-specific fragments of the M17Sl allele 2 and constant bands. While the two hybrids carrying derivatives of balanced translocations in the NF1 gene, DCR-1 (lane 3) and NF13 (lane 4), show no human-specific fragments, M17S1 homologous bands were observed in the hybrid SP3-10 (lane 5). SP3-10 clearly has the two fragments of the M17S1 allele 2 and the constant bands. These data map the M17S1 gene to the region between the SP3-10 and DCR-1 breakpoints.
To determine whether the M17S1 gene was embedded within the NF1 gene, we hybridized the M17S1 cDNA to three overlapping NFI-YACs that together span the entire >300 kb of the NF1 gene (Marchuk et al., 1992; Fig. 5) . As shown in Fig. 4A , the NF1-YACs carried no fragments homologous to M17S1. The membrane was hybridized in the same bag as the membrane shown in Fig.  3 , demonstrating that the hybridization reaction was successful. To confirm the presence and integrity of NF1-YAC DNA on the blot, it was stripped and simultaneously rehybridized to P5 and GE2, two NF1 cDNA fragments known to map within the YAC clones (Marchuk et al., 1992; Fig. 5) . Figure 4B demonstrates that the quality of the Southern blot was sufficient to generate a detectable signal upon hybridization to a singlecopy gene probe. In a separate experiment, no detectable hybridization was observed between the M17S1 cDNA and DNA from non-YAC-bearing yeast (data not shown). These data show unambiguously that the M17S1 gene is not embedded within the NF1 gene.
To further define the location of M17S1 in the region centromeric to NF1, it was mapped on UWA106-3, an NF1 patient that we have recently identified with an extensive deletion encompassing an entire NF1 allele (Materials and Methods; Kayes et al., 1992; Fig. 5) . The M17S1 alleles of UWA106-3 are shown in Fig. 3B in comparison to three unrelated, unaffected individuals displaying the three possible allele combinations at the locus. Lane 4 shows that UWA106-3 is either homozygous or hemizygous for allele 2 of M17S1. The copy number of M17S1 in DNA from peripheral blood for patient UWA106-3 was determined by densitometry of the autoradiograms in Figs. 3B and 3C as described under Materials and Methods. The M17S1/L946 density ratios were equivalent for the control individual and UWA106-3:0.807 and 0.779, respectively. These data show that the deletion carried by UWA106-3 does not include the M17S1 gene.
DISCUSSION
Using both genetic and physical breakpoints, we have mapped the gene for a novel epidermal antigen, M17S1, to a small q-proximal interval of chromosome 17. Genetic mapping was facilitated by the identification and characterization of a two-allele M17S1 polymorphism with a PIC of 0.27 revealed by the restriction enzyme PstI (Fig. 1) . Ten other restriction enzymes tested did not reveal any apparent polymorphism with the M17S1 cDNA, pESA2.
As predicted from the in situ hybridization data mapping M17S1 to chromosome bands 17qll-q12 (Schroeder et al., 1991) , lod score analyses demonstrated that M17S1 was linked to loci in this region. The genotype for the M17S1 PstI polymorphism and the polymorphisms for seven additional probe/enzyme systems were determined for individuals of 18 NF1 families. These families were chosen from our large repository of NF1 families because they would provide the maximum information; each family contained individuals with previously defined recombination events in the chromosome 17 pericentromeric region . Significant evidence in favor of tight linkage between M17S1 and four pericentromeric loci was obtained: NF1, D17S57, D17S73, and D17S54 (Table 1) .
Multipoint linkage analyses were performed to map the location of the M17S1 gene relative to other pericentromeric loci. Significant evidence in favor of placement of the M17S1 gene between the loci D17S58 and D17S54 (Fig. 2) , an interval known to contain the NF1 gene, was obtained. These data, in addition to the in situ data mapping M17S1 to chromosome band 17qll-q12 (Schroeder et al., 1991) , map the M17S1 gene to a 13-cM interval between the centromere (D17Z1) and D17S54 (Figs. 2 and 5) .
Since finer genetic mapping of M17S1 would require a large number of meioses or a more informative RFLP, we chose to use physical breakpoints to further localize the gene. The M17S1 gene was not found in two hybrid cell lines (DCR-1 and NF13) carrying derivative chromosomes 17 with breakpoints in the NF1 gene (Figs. 3 and 5) . These data narrowed the interval containing the M17S1 gene to a location between the centromere (D17Zl) and the DCR-1 breakpoint near the 3' end of the NF1 gene (Fig. 5) . The presence of M17S1 homologous sequences in the hybrid SP3-10, which carries the entire NF1 gene plus additional centromeric-proximal sequences (Fig. 5, van Tuinen et al., 1987; Fain et al., 1989; Fountain et al., 1989) , suggested that the M17S1 gene was either near the 5' end, or embedded within, the NF1 gene.
To determine whether the M17S1 gene was embedded within the NF1 gene, we hybridized the pESA2 cDNA to three NF1-YACs that form a contig encompassing the entire NF1 gene (Marchuk et al., 1992) . As shown in Fig.  4 and summarized in Fig. 5 , M17S1 homologous sequences were not detected in any of the YACs. These data demonstrate unambiguously that the M17S1 gene is not embedded within the NF1 gene. The possibility that M17S1 may map adjacent to the 5' end of the NF1 gene was also excluded; YAC A43A9 carries approximately 180 kb of DNA upstream of the 5' end of the NF1 gene (Marchuk et al., 1992; Fig. 5) . These data narrowed the interval carrying the M17S1 gene to a location between the hybrid SP3-10 breakpoint and 180 kb centromere-proximal to the NF1 gene (Fig. 5) .
Additional data mapped the M17S1 gene between the SP3-10 translocation breakpoint and the deletion breakpoint of individual UWA106-3. UWA106-3 is an NF1 patient carrying a large deletion encompassing an entire NF1 allele and contiguous genetic material (Kayes et al., 1992; Fig. 5) . Densitometric analysis showed that UWA106-3 had two copies of the M17S1 gene (Fig. 3) , proving that M17S1 was located outside this deletion.
In our previous study, the proximal extent of the deletion in UWA106-3 had not been established unambiguously with respect to the 5' end of the NF1 gene (Kayes et al., 1992) . D17S120, the most centromeric-proximal locus deleted in UWA106-3, was thought to map 5' to the NF1 gene since a microcell fusion breakpoint separated the two, but conclusive evidence was not available (Fain et al., 1989) . The NF1-YAC contig clones provided the opportunity to precisely define the proximal deletion breakpoint of UWA106-3. Southern blot hybridization of the YACs proved that D17S120 is not within the NF1 gene (data not shown). Therefore, the UWA106-3 deletion breakpoint lies a minimum of 180 kb centromeric to the NF1 promotor. These data confirm our previous conclusion that the NF1 phenotype appears to be the result of inactivation of one allele, rather than by the action of an abnormal neurofibromin protein product (Kayes et al., 1992) and provide a well-defined breakpoint for mapping other loci in the 17q centromereproximal region.
The interval between the SP3-10 translocation and UWA106-3 deletion breakpoints contains at least one additional gene, ~-crystallin, and the anonymous loci D17S33 (pHHH202), D17S82 (pTH17.19), and D17Sl16 (pVAW211) Fain et al., 1989) . The estimated minimum genetic distance of the interval is 0.6 cM, the sex-averaged genetic distance between NF1 and D17S33 . pHHH202, the probe for locus D17S33, detects and lies <220 kb distal to the SP3-10 breakpoint . Although the M17S1 gene is tightly linked to, and physically near the NF1 gene, the results of this study show that it is not embedded within the NF1 gene, nor is it physically close enough to likely be disrupted by the majority of mutations causing the NF1 disorder. Only a large deletion or complex chromosomal rearrangement could involve the M17S1 gene, located >180 kb proximal to the NF1 gene; such rearrangements of the NF1 gene appear to be uncommon (Upadhyaya et al., 1990) . Therefore, defects in M17S1 expression probably do not contribute to the skin manifestations or variable expressivity of NF1.
